Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Hib Vaccine Resources

One of the Recommended Vaccines by Disease

Zostavax® was licensed by the FDA in 2006. This vaccine reduces the risk of developing shingles by 51% and post-herpetic neuralgia (PHN) by 67%. It is administered subcutaneously as a single dose, and can be given in a doctor’s office or pharmacy. CDC recommends shingles vaccine (Zostavax) for people age 60 years and older. Even people who have had shingles can receive the vaccine to help prevent future occurrences of the disease.

Below are a number of resources designed to help healthcare professionals recommend and administer Haemophilus influenzae type b (Hib) vaccines, as well as answer patient questions.

Vaccine Safety


Provider Education


Materials for Patients


Clinical Information


References and Resources